Sandoval MRL

Language: Spanish
References: 30
Page: 38-48
PDF size: 118.57 Kb.

ABSTRACT

The Human Immunodeficiency Virus (HIV) infection and its consequence the Acquired Immunodeficiency Syndrome (AIDS), is considered as chronic inflammatory entity; for this reason the nutritional support and management is the same as any other related disease. Therefore prevention and treatment of malnutrition is an integral part of management disease. The goal is to achieve the theorical weight, the best body composition and immunological function to decrease the opportunistic infection frequency, a better response to them and delay the course of the disease. For practical purposes, two categories of nutritional support have been established, a) nutrient replacement (by an adequate oral diet or artificial nutrition) and b) pharmacological modality with nutrients like arginine, glutamine, nucleotides, they play a role as pharmaconutrient given in higher doses than recommended. With this category, we attempt to modify the metabolic changes caused by the morbid condition. This work is a review of important and new concepts related to nutritional support in this field.

REFERENCES

1. Fields-Gardner C. Position of the American Dietetic Association and The Canadian Dietetic Association: Nutrition intervention in the care of persons with human immunodeficiency virus infection. J Am Diet Assoc 1994;94:1042-1045.

2. Cheblowski RT, Grosvenor M, Lillington L, et al. Dietary intake and counseling, weight maintenance, and the course of HIV infection. J Am Diet Assoc 1995;95:428-432.

3. Jain VK, Chandra RK. Does nutritional deficiency predispose to acquired immunodeficiency syndrome? Nutr Res 1984;4:537-543.

4. McKinley MJ, Goodman-Block J, Lesser M, et al. Improved body weight status as a result of nutrition intervention in adult HIV-positive patients. J Am Diet Assoc 1994;94:1014-1017.

5. Kaplan JE, Masur H, Holmes KK, et al. USPHS/IDSA Prevention of opportunistic infections working group: USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with HIV. Intro Clin Infect Dis 1995;21:S1-S11.

6. Health Canada. Canada’s food guide to healthy living. Ottawa: Health Canada. 1997 June.

7. Hellerstein MK, Wu K, et al. Effects of dietary n-3 fatty acid supplementation in men with weight loss associated with the acquired immune deficiency syndrome: Relation to indices of cytokine production. Journal of Acquired Immunodeficiency Syndrome and Human Retrovirology 1993;11:258-270.

8. Baum MK, Shor-Posner G, et al. Micronutrients and HIV-1 disease progression. AIDS 1995;9:1056-6.

9. Tang AM, Graham NM, et al. Effects of micronutrient intake on survival in human immunodeficiency virus type 1 infection. American Journal of Epidemiology 1996;143:1244-56.

10. Tang AM, Graham NM, et al. Association between serum vitamin A and E levels and HIV-1 disease progression. AIDS 1997;11:613-20.

11. Baum MK, Shor-Posner G. High risk of HIV-related mortality is associated with selenium deficiency. Journal of Acquired Immunodeficiency Syndrome and Human Retrovirology 1997;15:370-374.

12. Lawless D, Jackson C, et al. Exercise and human immunodeficiency virus (HIV-1) infection. Sports Medicine 1995;19:235-9.

13. Beach RS, Mantero-Atienza E, et al. “Specific nutrient abnormalities in asymptomatic HIV-1 infection”, AIDS 1992;6:701-708.

14. Bogden JD, Baker H, et al. “Micronutrient status and human immunodeficiency virus (HIV) infection”, Annals of the New York Academy of Sciences. 1990;587:189-195.

15. Evans MA, Shronts EP. Intestinal fuels: glutamine, short-chain fatty acids, and dietary fiber. J Am Diet Assoc 1992;92:1239-1246,1249.

16. Haw MP, Bell Sj. Blackburn GL. Potential of parenteral and enteral nutrition inflammation and immune dysfunction: a new challenge for dietitians. J Am Diet Assoc 1991;9:701-709.

17. Wan JM, Teo TC. Babayan Vk et al. Invited comment lipids and the development of immune dysfunction and infection. J Parenter Enter Nutr 1988;12:45S-52S.

18. Sardesai VM. The essential fatty acids. Nutr Clin Pract 1992;7:179-186.

19. Kinsella JE, Lokesh B. Dietary lipids, eicosanoids and the immune system. Crit Med 1990;18:S94-S113.

20. Sucher KP. Medium-chain triglycerides: a review of their use in clinical nutrition. Nutr Clin Prac 1986;1:146-150.

21. Silk DBA, Fairclough PD, Clark ML, et al. Use of peptide rather than free amino acid nitrogen source in chemically defined elemental diets. J Parenter Enter Nutr 1980;4:548-553.

22. Adibi S, Phillips E. Evidence for greater absorption of amino acid from peptide than from free in human intestine. Clin Res 1968;16:446.

23. Heyland DK, Cook DJ. Guyatt GH. Does the formulation of enteral feedding products influence infectious morbidity and mortality rates in the critically ill patient A critical review of the evidence. Crit Care Med 1994; 22:1192-1202.

24. Lacey JM, Wilmore DW. Is glutamine a conditionally essential amino acid. Nutr Rev 1990;48:297-309.

25. Souba W, Smith RJ, Wilmore DW. Glutamine and the preservation of gut integrity. Lancet 1993;341:1363-1365.

26. Smith RJ, Wilmore DW. Glutamine nutrition and requirements. J Parenter Enter Nutr 1990;14:94S-99S.

27. Ziegler TR, Benfell K, Smith RJ, et al. Safety and metabolic effects of L-glutamine administration in humans. J Parenter Enter Nutr 1990;14:137S-146S.

28. Fisher JE, Chance WT. Total parenteral nutrition, glutamine and tumor growth. J Parent Enter Nutr 1990;14:86S-89S.

29. Matarese LE. Rationale and efficacy of specialized enteral nutrition. Nutr Clin Prac 1994;9:58-64.

30. Kotler DP, Tierney AR, Altilio D, et al. Body mass repletion during ganciclovir therapy of cytomegalovinus infections in patients with the acquired immunodeficiency syndrome. Arch Intern Med 1989;149:901-905.